Annual run/walk fundraiser to raise funds to support ovarian cancer education, awareness and research activities in the greater Sacramento community.
Let's ROC is the only run/walk held in Northern California specifically for ovarian cancer.
- Since its inception the race has averaged 1000 participants each year and raised over $100,000
- We donate 75% of the race's net proceeds to an ovarian cancer research grant
OCERN awards annually a research grant for established and junior investigators to initiate new studies or further existing research related to ovarian cancer. Research proposals may be individual projects or part of a larger research project. Awards are granted to projects conducted in the state of California by California-based researchers. It is our goal to increase the amount and number of research grants we award in the future.
- Research grants in the amounts of $25,000 were awarded in 2014, 2015, and 2016.
View 2016 Research Grant update here: https://vimeo.com/197978330
- Speakers Bureau: Presentation on the risks and symptoms of ovarian cancer to community and professional organizations, and academic institutions
- Survivors Teaching Students: Saving Women's Lives: OCERN participates in the Ovarian Cancer National Alliance's Survivors Teaching Students (STS) program in Sacramento and coordinate the STS program at Stanford University; Survivors Teaching Students brings ovarian cancer survivors into the classroom, where they present their stories along with facts about the disease to future physicians, nurse practitioners, nurses and physician assistants
While OCERN was officially formed as a nonprofit in 2012, we have partnered with local organizations for nearly a decade to conduct annual presentations on the risks and symptoms of ovarian cancer. With our participation in the STS program, we are using our personal stories and experience to educate new health care providers about ovarian cancer. The intent is to help a future practitioner think twice about a woman's symptoms and consider ovarian cancer first, hopefully resulting in an early diagnosis.